STEEN Solution™: Clinical Trials

2 trials of STEEN Solution™, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1

Follow STEEN Solution™: new trials by email Literature Review of STEEN Solution™ trials Research Report on STEEN Solution™

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™, STEEN Solution™ - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Not applicableCompletedUniversity of North Carolina, Chapel Hill242013-09-012018-06-08
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Steen Solution™, Conventional Lung Transplant - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Not applicableTerminatedUniversity of North Carolina, Chapel Hill112010-12-012018-07-13

Conditions studied

Bronchiectasis (2)  ·  Cystic Fibrosis (2)  ·  Emphysema (2)  ·  Hypertension, Pulmonary (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Pulmonary Fibrosis (2)  ·  Sarcoidosis (2)  ·  alpha 1-Antitrypsin Deficiency (2)

Sponsors

University of North Carolina, Chapel Hill (2)

Countries

United States (2)

Top investigators

Thomas M. Egan, MD, MSc. (2)

Results publications

PMID 28945476

NIH funding

1UM1HL113115-01A1 (1)